Introduction {#s1}
============

Since the index case in 2013, the West African Ebola epidemic has killed more than 11,000 people ([@bib38]) and exposed national and international inadequacies in pandemic preparedness and response ([@bib19]). In 2014 a zoonotic niche map for Ebola virus disease (EVD) was produced ([@bib27]) in part to assess the expected geographical extent of spillover risk. This research was then expanded to explore how changes in demography and international connectivity may have facilitated the establishment and rapid subsequent spread of the epidemic ([@bib3]). The West African outbreak of EVD has again highlighted key information gaps that exist with respect to the broader epidemiology of Ebola virus, particularly concerning viral persistence in reservoirs ([@bib6]; [@bib18]; [@bib12]), and prompted a variety of questions concerning the role bats play in transmission ([@bib13]). Identifying reservoirs of zoonotic disease is a complex process ([@bib34]; [@bib8]) and whilst considerable sampling effort has been undertaken over the years ([@bib11]; [@bib14]), isolation of Ebolavirus from living animals has been rare ([@bib16]). The original eLife study only incorporated the three bat species found to be RNA-positive ([@bib16]). Whilst this remains currently the best evidence for an animal reservoir species, it is important to consider that other sampling efforts may by chance represent false negatives, particularly if infection is rare.

Consequently, to contribute to these broader discussions, the original paper ([@bib27]) was updated with new occurrence data and expanded to consider a wider range of potential bat reservoir species. Bats remained the priority mammalian order given the previous viral isolation and the repeated anecdotal implications in previous outbreaks ([@bib15]; [@bib18]). Since there are a large number of bat species found in Africa, we defined three groupings, based upon the strength of evidence supporting their potential Ebola reservoir status. As a result, not only were the original three RNA-positive bats included ([@bib16]), but also those species with serological evidence of EVD infection ([@bib23]) and those identified through trait-based machine learning approaches as being similar to species already reporting filoviral infection ([@bib7]).

Results {#s2}
=======

Six additional records of EVD were incorporated into the disease occurrence database: one human outbreak in the Democratic Republic of Congo ([@bib17]); two reports of infections in animals in Zambia ([@bib22]); and three animal infections in Central African Republic([@bib20]) ([Figure 1](#fig1){ref-type="fig"}). Of these new occurrences, two in southern Central African Republic are found in areas predicted to be at-risk by the previous model ([@bib27]), with the index case from the Democratic Republic of Congo located in close proximity (\<10 km) to at-risk areas. The occurrences in Zambia and northern Central African Republic lie, respectively, to the south and north of previously predicted at-risk regions.10.7554/eLife.16412.002Figure 1.Updated Ebola virus disease occurrence database.Human index cases are represented by red circles, animal occurrences in blue. New occurrence information is indicated by the black circle. The coordinates of polygon centroids are displayed for occurrences defined by an area greater than 5 km x 5 km.**DOI:** [http://dx.doi.org/10.7554/eLife.16412.002](10.7554/eLife.16412.002)

[Figure 2](#fig2){ref-type="fig"} depicts the three new consolidated bat distributions. The revised distribution of the Group 1 bats (*i.e.* those found to have been Ebolavirus RNA positive) is broadly consistent with that published in the original paper except that the peripheries of Central Africa are now predicted to be environmentally suitable for these bats, as well as some parts of East Africa, particularly Tanzania, Mozambique and Madagascar. The Group 2 and Group 3 bat species are predicted to be distributed across much of Africa stretching from West to East Sub-Saharan Africa, as well as much of the coastline of the continent.10.7554/eLife.16412.003Figure 2.Combined suitability surfaces for each of the potential reservoir bat groupings.For each layer the species specific suitability maps were combined to produce a surface approximating the probability that any bat species in that group may be present. Regions in blue (1) are most environmentally similar to locations reporting bat records. Areas in yellow (0) are the least environmentally similar. The top left panel depicts Group 1, top right Group 2 and bottom left Group 3 bats.**DOI:** [http://dx.doi.org/10.7554/eLife.16412.003](10.7554/eLife.16412.003)10.7554/eLife.16412.004Figure 2---figure supplement 1.Group 1 bat distributions.The environmental suitability for each of the three bat species in Group 1 are displayed. Regions in dark blue (1) are most environmentally similar to locations reporting bat records. Areas in white (0) are the least environmentally similar. The black outline depicts the expert opinion range maps as determined by the International Union for the Conservation of Nature ([@bib32]) and the black dots represent occurrence records reported by the Global Biodiversity Information Facility ([www.gbif.org/](http://www.gbif.org/)) and from published peer-reviewed articles. From top left, clockwise: *Epomops franqueti, Hypsignathus monstrosus*, summary Group 1 layer combining all three maps, and *Myonycteris torquata*.**DOI:** [http://dx.doi.org/10.7554/eLife.16412.004](10.7554/eLife.16412.004)10.7554/eLife.16412.005Figure 2---figure supplement 2.Group 2 bat distributions.The environmental suitability for each of the five bat species in Group 2 are displayed. Regions in dark blue (1) are most environmentally similar to locations reporting bat records. Areas in white (0) are the least environmentally similar. The black outline depicts the expert opinion range maps as determined by the International Union for the Conservation of Nature ([@bib32]) and the black dots represent occurrence records reported by the Global Biodiversity Information Facility ([www.gbif.org/](http://www.gbif.org/)). From top left, clockwise: *Tadarida condylura, Rousettus aegyptiacus, Miniopterus pusillus*, summary Group 2 layer combining all five maps, *Eidolon helvum,* and *Epomophorus gambianus*.**DOI:** [http://dx.doi.org/10.7554/eLife.16412.005](10.7554/eLife.16412.005)10.7554/eLife.16412.006Figure 2---figure supplement 3.Group 3 bat distributions.The environmental suitability for each of the seven bat species in Group 3 are displayed. Regions in dark blue (1) are most environmentally similar to locations reporting bat records. Areas in white (0) are the least environmentally similar. The black outline depicts the expert opinion range maps as determined by the International Union for the Conservation of Nature ([@bib32]) and the black dots represent occurrence records reported by the Global Biodiversity Information Facility ([www.gbif.org/](http://www.gbif.org/)). From top left, clockwise: *Epomops buettikoferi, Miniopterus schreibersii, Epomophorus labiatus, Miniopterus inflatus*, summary Group 3 layer combining all seven maps, *Otomops martiensseni, Hipposideros gigas,* and *Rhinolophus eloquens*.**DOI:** [http://dx.doi.org/10.7554/eLife.16412.006](10.7554/eLife.16412.006)

The revised niche map, incorporating the updated bat covariates and disease occurrence database, is presented in [Figure 3](#fig3){ref-type="fig"}. The map shows the predicted areas of environmental suitability for zoonotic Ebola virus transmission to be consistent with previous attempts, but the relative environmental suitability within this distribution differs from the previous estimates. [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} demonstrates that Cameroon, Gabon, Republic of Congo and mainland Equatorial Guinea are now predicted to be more environmentally suitable than in the previous analysis. The regions of Central Africa (particularly Gabon and the Republic of Congo) identified as being most environmentally suitable for zoonotic EVD transmission in the previous analysis remain so in this analysis. The revised number of predicted at-risk countries, determined by thresholding the map by a probability that captures 95% of the occurrence dataset, is 23 ([Table 1](#tbl1){ref-type="table"}).10.7554/eLife.16412.007Figure 3.Updated map showing areas most environmentally suitable for the zoonotic transmission of Ebola virus.Areas closer to dark red (1) are most environmentally similar to locations reporting Ebola virus occurrences; areas in light yellow (0) are least similar. Countries with borders outlined are those which are predicted to contain at-risk areas for zoonotic transmission based on a thresholding approach. Output displayed generated from model using the three consolidated bat covariates.**DOI:** [http://dx.doi.org/10.7554/eLife.16412.007](10.7554/eLife.16412.007)10.7554/eLife.16412.008Figure 3---figure supplement 1.Absolute differences between previous and revised maps.Generated by subtracting the original eLife publication pixel probabilities from the newly generated values and restricted to those areas determined to be at-risk. Areas in yellow are essentially consistent. Areas in purple have probability values greater than the previous output; areas in green have probability values lower than previous outputs.**DOI:** [http://dx.doi.org/10.7554/eLife.16412.008](10.7554/eLife.16412.008)10.7554/eLife.16412.009Figure 3---figure supplement 2.Zoonotic niche map based upon inclusion of individual bat covariate layers.Areas closer to dark red (1) are most environmentally similar to locations reporting Ebola virus occurrences; areas in light yellow (0) are least similar. Countries with borders outlined are those which are predicted to contain at-risk areas for zoonotic transmission based on a thresholding approach. Output displayed generated from model using individual bat covariate layers.**DOI:** [http://dx.doi.org/10.7554/eLife.16412.009](10.7554/eLife.16412.009)10.7554/eLife.16412.010Table 1.National populations at risk.**DOI:** [http://dx.doi.org/10.7554/eLife.16412.010](10.7554/eLife.16412.010)CountryPopulation-at-risk (in 100,000s)Countries previously\
reporting index casesDemocratic Republic of the Congo170.18Uganda21.58Guinea17.61Côte d'Ivoire4.08Gabon3.65South Sudan1.80Republic of Congo1.07Countries with no\
reported index casesNigeria29.13Cameroon22.90Central African Republic7.62Liberia5.88Ghana4.04Sierra Leone3.94Angola3.25Togo1.78Ethiopia1.75Equatorial Guinea1.22Tanzania1.18Burundi1.07Mozambique0.55Madagascar\<0.1Kenya\<0.1Malawi\<0.1

The similar AUC values (0.85 ± 0.04 compared to 0.8236 ± 0.080) between the previous and current iterations suggest that the updated model fits the new occurrence dataset as well as the previous model fitted the older dataset. Mean enhanced vegetation index (EVI) remains the highest relative predictor covariate for zoonotic EVD transmission while the relative importance of Group 1 bat distributions moved from being the fifth most important to the second. Mean night-time land surface temperature (LST), elevation and mean daytime LST complete the top five predictors ([Table 2](#tbl2){ref-type="table"}).10.7554/eLife.16412.011Table 2.Comparison of previous and revised niche models.**DOI:** [http://dx.doi.org/10.7554/eLife.16412.011](10.7554/eLife.16412.011)Revised niche map (with summary bat layers)Revised niche map (with individual bat layers)Previous eLife niche map ([@bib27])AUC0.8236 ± 0.080.8195 ± 0.080.85 ± 0.04Occurrencesn = 57 (animals), n = 31 (humans)n = 57 (animals), n = 31 (humans)n = 51 (animals), n = 30 (humans)Ranked relative contributionsEVI mean (0.55)EVI mean (0.46)EVI mean (0.65)Group 1 bat distribution (0.18)*Hypsignathus monstrosus* (0.15)Elevation (0.12)LST mean (night) (0.08)*Epomops franqueti* (0.08)LST mean (night) (0.08)Elevation (0.06)*Otomops martiensseni* (0.06)PET mean (0.06)LST mean (day) (0.04)*Epomophorus labiatus* (0.04)Bat distribution (0.04)

When separate bat layers were used in the model, as opposed to the consolidated covariates, the predictions were geographically similar ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}) however, four bat species were identified as explaining more of the variation than the rest; *Hypsignathus monstrosus, Epomops franqueti* (from both of which Ebolavirus RNA has been isolated), *Otomops martiensseni* and *Epomophorus labiatus* (both from Group 3). The explanatory power of this model (evaluated using AUC) was comparable to the model results described above (AUC = 0.819 ± 0.080).

Discussion {#s3}
==========

This research advance integrates new data as well as a more thorough consideration of the bat species that act as a reservoir for the virus in order to update our modelled estimate of the zoonotic niche of EVD. The area estimated to be at potential risk of zoonotic EVD transmission has now expanded to include Kenya and the influence of additional bat species demonstrates that continued focus should be placed on rigorously identifying reservoir species and the role they play in sustaining viral transmission ([@bib12]). The fact that *O. martiensseni* and *E. labiatus* contribute explanatory power to the model, in comparison with their distributions on the eastern and southern periphery of reported cases of EVD ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}) suggests that different regions of the continent may support transmission cycles with differing reservoir species. This, coupled with the potential for each of the pathogenic species of *Ebolavirus* potentially having differing distributions ([@bib24]), cannot currently be explored more rigorously due to insufficient data.

As with the original publication, it must be reiterated that environmental suitability does not inevitably lead to spillover events. Currently absolute human population residing in at-risk pixels is used as a proxy for spillover likelihood, however, a variety of factors will influence the outbreak risk within each location ([@bib29]) and only by including covariates that consider human behaviour ([@bib37]), patterns of susceptibility in other animals ([@bib36]; [@bib35]), impacts of land use change ([@bib30]) and within-host viral dynamics ([@bib2]; [@bib9]) can an approximation of spillover risk be defined.

These updates demonstrate the ease and speed with which new data and covariate considerations can be incorporated within existing empirical models ([@bib10]). As the wider discussion on EVD turns to focus on strategies to prevent or contain future spillover events as well as developing long-term in-country containment capacities ([@bib4]), it is hoped that maps such as these convey the heterogeneities in spillover risk that exist within Africa. To better enable researchers and policymakers to consider EVD preparedness and necessary contingencies, a new online tool has been developed which allows users to interrogate the revised maps in more detail, in areas of specific interest (<http://vizhub.healthdata.org/ebola>). As part of this tool, the zoonotic niche output and Group 1 bat layers are now available, along with filters for identifying at-risk countries and locations of previous index cases from outbreaks.

Geographic datasets such as these provide context to broader discussions as our aspirations transition from controlling outbreaks to mitigating the risk of future spillover events prioritised by their potential for more widespread epidemics. Such data are particularly important for determining where best to investigate the frequency of potentially transmissible contacts between reservoir and susceptible species and humans. Previous niche maps served as an important impetus in the search for potential reservoirs ([@bib25]) and these iterations can continue to inform such work. As researchers and policy makers seek to resolve outstanding questions about EVD epidemiology, it is hoped that the continued updating and dissemination of this information can contribute to this discussion.

Materials and methods {#s4}
=====================

Updating the occurrence database {#s4-1}
--------------------------------

Since the previous publication, an outbreak of EVD occurred in humans in the Democratic Republic of the Congo ([@bib17]). The outbreak is thought to have originated in Inkanamongo, a village near Boende, Équateur province and resulted in 66 probable and confirmed cases and 49 probable and confirmed deaths ([@bib31]). A polygon of radius 10 km centered on the town of Boende was included to capture the location of the index case, increasing the database of assumed independent animal-to-human spillover events to 31 as part of 24 distinct reported outbreaks ([@bib21]).

In addition, a re-analysis of the literature available on infections in animal species was completed on 7^th^ October 2015. Due to the poor differential capacity of immunological tests to discriminate Ebola virus from other viruses we retained the following inclusion criteria for the database; for susceptible species mortality events linked to Ebolavirus by any diagnostic methodology *or* PCR-positive diagnosis of Ebolavirus were included. Inclusion criteria for potential bat reservoir species were either PCR-positivity or serological evidence suggesting Ebolavirus infection. Serological studies were included without fatal outcomes (unlike with susceptible species) due to the hypothesised asymptomatic nature of infection in the reservoir hosts. As a result of these inclusion criteria, studies with serological detection of Ebolavirus in healthy non-Chiropteran species were excluded, such as surveys in dogs ([@bib1]).

In total six new records of EVD occurrence in animals were identified and included within the database to increase the total to 57. These records were obtained from two research articles. The first of these assessed Ebolavirus load in a variety of mammal species and identified PCR-positivity in a number of small mammals across three sites in Central African Republic ([@bib20]). In total, four separate occurrences, consisting of three different species, were identified as being PCR positive: a member of the *Praomys* complex, Peter's mouse (*Mus setulosus*) and the greater forest shrew (*Sylvisorex ollula*). The second study investigated serological responses in straw-coloured fruit bats (*Eidolon helvum*) caught in two districts in Zambia ([@bib22]). Specific latitudes and longitudes of the study sites were supplied for the Central African Republic study and were used to generate point occurrences. For the Zambian study it was necessary to use administrative data representing the two districts where the bats were caught (Serenje and Ndola districts).

Expanding potential bat reservoir species {#s4-2}
-----------------------------------------

Potential bat reservoir species were stratified into three groupings based upon the strength of evidence suggesting their reservoir status ([Table 3](#tbl3){ref-type="table"}). Group 1 contained the three species of bat from which Ebolavirus RNA has been detected and therefore have the strongest evidence to support potential reservoir status ([@bib16]). Group 2 species are those that, using a variety of serological tests, have been reported to be Ebolavirus seropositive, suggesting potential reservoir status. A previous review ([@bib23]), identified nine species as seropositive for Ebolavirus. This was reduced to five species after the removal of the three species already categorised in Group 1 and Leschenault's Rousette, *Rousettus leschenaultii*, which is not found in Africa.10.7554/eLife.16412.012Table 3.Final bats included in analysis classified by evidence grouping.**DOI:** [http://dx.doi.org/10.7554/eLife.16412.012](10.7554/eLife.16412.012)GroupingBatOccurrencesGroup 1Franquet's epauletted fruit bat\
(*Epomops franqueti*)442Hammerheaded fruit bat\
(*Hypsignathus monstrosus*)254Little collared fruit bat\
(*Myonycteris torquata*)107Group 2Angolan free-tailed bat\
(*Tadarida condylura*, formerly *Mops condylurus*)179Egyptian fruit bat\
(*Rousettus aegyptiacus*)177Gambian epauletted fruit bat\
(*Epomophorus gambianus*)166Peter's dwarf epauletted fruit bat\
(*Micropteropus pusillus*)208Straw-coloured fruit bat\
(*Eidolon helvum*)282Group 3Buettikofer's epauletted fruit bat\
(*Epomops buettikoferi*)50Common bent-wing bat\
(*Miniopterus schreibersii*)31Eloquent horseshoe bat\
(*Rhinolophus eloquens*)61Ethiopian epauletted fruit bat\
(*Epomophorus labiatus*)187Giant leaf-nosed bat\
(*Hipposideros gigas*)21Greater long-fingered bat\
(*Miniopterus inflatus*)56Large-eared free-tailed bat\
(*Otomops martiensseni*)33

Finally, Group 3 species were identified *via* generalized boosted regression analysis, which discriminates the bats reported to be filovirus-positive by learning trait patterns that distinguish them from all other bat species ([@bib7]). Generalized boosted regression ([@bib5]) was applied to traits describing all bat species, including life history, physiological, ecological, morphological and demographic variables collected from numerous published sources. In addition to traits, the filovirus status of each bat species was assigned as a binary score (0 -- not currently known to be positive for any filoviruses; 1 -- published evidence). This analysis produces a rank list of all bat species according to their probability of being a filovirus carrier on the basis of their trait similarities with known filovirus-positive bat species. Bats found in the 90^th^ percentile of likely filovirus carriers were initially considered, and then filtered to include only those which have home ranges in Africa ([@bib32]). As per the original publication, occurrence records were extracted from the Global Biodiversity Information Facility (GBIF). Species for which there were fewer than 20 unique GBIF records in Africa were dropped from the analysis due to data paucity. [Table 3](#tbl3){ref-type="table"} reports the bat species and corresponding numbers of occurrences included in the analysis.

For Group 1 species, occurrence records were supplemented by searching PubMed and Web of Knowledge for additional reports. A literature review was completed on the 8^th^ September 2015 using the following sets of keywords:

-   \'*Hypsignathus monstrosus*\' or \'hammer-headed bat\' or \'hammer headed bat\' or \'hammerheaded bat\' or \'big-lipped bat\' or \'big lipped bat\' or \'*Hypsignathus labrosus*\' or \'*Hypsignathus macrocephalus*\'

-   \'*Myonycteris torquata*\' or \'little collared fruit bat\' or \'*Myonycteris collaris*\' or \'*Myonycteris leptodon*\' or \'*Myonycteris wroughtoni*\'

-   \'Epomops franqueti\' or "Franquet's epauletted fruit bat" or \'Epomops comptus\' or \'Epomops strepitans\'

A total of 34 articles were identified for inclusion, from which 564 additional occurrences were sourced.

All bat species were modelled separately using boosted regression trees ([@bib5]) utilising the same modelling procedure as outlined in the original article except that 100, rather than 50, bootstrap models were fitted. This resulted in 15 individual environmental suitability maps for bat species (see [Figure 2---figure supplements 1](#fig2s1){ref-type="fig"}, [2](#fig2s2){ref-type="fig"} and [3](#fig2s3){ref-type="fig"}), as well as three consolidated bat layers combining the environmental suitability maps for the bats within each of the three groupings ([Figure 2](#fig2){ref-type="fig"}).

Revising the predicted zoonotic niche map {#s4-3}
-----------------------------------------

A species distribution model, specifically a boosted regression trees approach ([@bib5]), was implemented. The model generates regression trees based upon binary splits of linked covariates, which are iteratively improved upon by boosting. The regression trees are capable of characterising complex environmental interactions and correlations since each tree is built from a hierarchy of multiple nodes, each based upon different successive binary splits of the covariates. The model extracts environmental information for each reported occurrence of Ebolavirus to define an optimal relationship between presence of the disease and environmental factors. Predictive performance is improved by including a comparison background dataset that acts as a hypothesised environmental negative control ([@bib26]). As per the previous analysis, this dataset was generated by randomly sampling across Africa biased towards areas of high population density. By including human population density in this way, some potential sampling biases present in human index case reporting can be mitigated as cases are more likely to be reported in more populous areas. The boosted regression trees were re-run using the same parameters and covariates (elevation, mean evapotranspiration rate, and mean and range measures of enhanced vegetation index, daytime land surface temperature (LST), and night-time LST) as the previous publication except for the inclusion of the new occurrence data outlined above and the new bat layers. Two model iterations were run: one with the three consolidated bat layers (i.e. Groups 1, 2 and 3) and the other with all the bat species layers considered separately.

Estimating populations at risk {#s4-4}
------------------------------

The continuous suitability surface was converted into a binary at-risk versus not-at-risk surface by determining a threshold value that included 95% of the estimated suitability values of pixels with reported human index cases ([@bib28]). For sites represented by a specific latitude and longitude the suitability score was taken from the corresponding pixel; for polygon estimates covering a number of cells, the mean suitability was taken across all pixels covered by the polygon.

Whilst not included directly as a covariate in the modelling process, human population layers were assessed in at-risk locations as a potential proxy for spillover frequency. The populations living within the gridded cells thought to be at-risk of potential Ebolavirus transmission from zoonotic sources were calculated using an updated contemporary gridded estimate of population ([@bib39]).
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Updates to the zoonotic niche map of Ebola virus disease in Africa\" for consideration by *eLife*. Your article has been reviewed by Pasi Penttinen and Armand Sprecher, and the evaluation has been overseen by a Reviewing Editor and Prabhat Jha as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The reviewers and Reviewing Editor felt that this update to your previous model on the zoonotic niche for Ebola virus disease in Africa (Pigott et al. 2014) addressed an important, original and timely research question. The study was well designed, analysed and presented. The manuscript is clearly written in good English, and was an interesting read.

While the reviewers supported the general idea of updating previous maps to incorporate new data, there were reservations in particular about the inclusion of bat groups 2 and 3 and the clinical inclusion of animal cases. We would like to see a revised manuscript with much more explanation and support for these inclusions (as detailed in major comment 1 below).

Essential revisions:

1\) The explanatory power from the two bats species in group 3 was interesting. However, it felt like a step had been omitted. The \"more thorough consideration of the bat species that act as a reservoir for the virus\" is a good idea, but it would seem one that requires being established first prior to incorporation into the map. The addition of groups 2 and 3 seems too casual here. For example, the paper admits in the Materials and Materials and methods section \"the poor differential capacity of immunological tests to discriminate Ebola virus from other viruses\" is such that weak clinical criteria need be used to identify infections in animal species, and then notes that the inclusion criterion for bat reservoir species were \"serological evidence suggesting Ebolavirus infection\". Furthermore, it is not clear how the nine bat species listed in [Table 1](#tbl1){ref-type="table"} of the Olival and Hayman article cited became the five species in Group 2. It is hard then for the reader to get very excited about the bats in Group 2 without more support.

For Group 3, the reader is even more at sea, as the referenced article is \"in review\", and all we know is that some machine learning routine sorted out some bat species according to likelihood of filovirus carriage somehow. That two species produced interesting explanatory power is interesting, but they have been drawn from a rather black box.

Hence we feel that there needs to be a much more thorough consideration of the bat species for the incorporation of these additions to be justified.

2\) Coming back to the criteria for inclusion of animal cases, the previous niche map seems to have used only those cases identified by serology and PCR. The current manuscript adds mortality and other clinical symptoms (subsection "Updating the occurrence database", second paragraph), noting this is consistent with inclusion criteria for humans. Importantly, the clinical inclusion criteria for humans are only used in the epidemic zone of a laboratory confirmed outbreak, and this is only for identification of suspect cases who will undergo subsequent laboratory testing (or if this is impossible, epidemiologic criteria may be used to identify probable cases). Ebola is a vague disease in humans, and may be nonspecific in animals. The clinical criteria the authors use are not given, and it is unclear how specific they might be. More information is needed on this to evaluate the suitability of inclusion on clinical grounds.

3\) You do not present or discuss how well the newly identified EVD events fit into their previous model. Please consider adding a layer with the previously published model (Figure 5B? from the 2014 publication) on [Figure 1](#fig1){ref-type="fig"} and/ or discuss how the newly identified events fit with the previous model.

4\) Spatial distribution of the human population is not incorporated in the model. It would be useful for more generalist readers to describe briefly how the boosted regression tree modelling takes (or not) into account the fact that it is quite possible that the human population density and environmental variables (including bat population density) are correlated. Hence, a fit with occurrences of zoonotic events might be partly a reflection of population density.

10.7554/eLife.16412.017

Author response

*Summary:*

The reviewers and Reviewing Editor felt that this update to your previous model onthe zoonotic niche for Ebola virus disease in Africa (Pigott et al. 2014)addressed an important, original and timely research question. The study was welldesigned, analysed and presented. The manuscript is clearly written in goodEnglish, and was an interesting read.

While the reviewers supported the general idea of updating previous maps toincorporate new data, there were reservations in particular about the inclusion ofbat groups 2 and 3 and the clinical inclusion of animal cases. We would like to see a revised manuscript with much more explanation and support for these inclusions (as detailed in major comment 1 below).

We thank the editors and reviewers for the overall positive comments. We havehopefully added sufficient details (outlined below) to respond to the concernsabout justifying additional reservoir species.

*Essential revisions:*

*1) The explanatory power from the two bats species in group 3 was interesting. However, it felt like a step had been omitted. The \"more thorough consideration of the bat species that act as a reservoir for the virus\" is a good idea, but it would seem one that requires being established first prior to incorporation into the map. The addition of groups 2 and 3 seems too casual here. For example, the paper admits in the Materials and methods section \"the poor differential capacity of immunological tests to discriminate Ebola virus from other viruses\" is such that weak clinical criteria need be used to identify infections in animal species, and then notes that the inclusion criterion for bat reservoir species were \"serological evidence suggesting Ebolavirus infection\".*

We have added additional text providing background information on potential reservoir host selection processes and why it is important, as well as discussing this within the context of Ebola virus disease (EVD). We have added the following text to the Introduction:

"Identifying reservoirs of zoonotic disease is a complex process (Viana et al. 2014, Haydon et al. 2002) and whilst considerable sampling effort has been undertaken over the years (Kuhn 2008; Leirs et al. 1999), isolation of Ebolavirus from living animals has been rare (Leroy et al. 2005). \[...\] Since there are a large number of bat species found in Africa, we defined three groupings, based upon the strength of evidence supporting their potential Ebola reservoir status. As a result, \[...\]"

Furthermore, it is not clear how the nine bat species listed in [Table 1](#tbl1){ref-type="table"} of the Olival and Hayman article cited became the five species in Group 2. It is hard then for the reader to get very excited about the bats in Group 2 without more support.

Olival and Hayman's review identifies nine species of bat as being positive for Zaire Ebolavirus by either serology or PCR. Of these nine, three (*Epomops franqueti*, *Hypsignathus monstrosus* and *Myonycteris torquata*) are already considered within Group 1 due to the PCR identification. Of the remaining six, one (*Rousettus leschenaultii*) is only found in Asia and therefore was excluded due to being out of the study geography. While these species may not be classified via gold-standard methods such as PCR, they represent a distinct grouping of potential reservoir species in comparison to other bat species (where no serological evidence has been found). We have added the following to the text to the Materials and methods section:

"Group 2 series are those that, using a variety of serological tests, have been reported to be Ebolavirus seropositive, suggesting potential reservoir status. A previous review (Olival & Hayman 2014), identified nine species as seropositive for Ebolavirus. This was reduced to five species after the removal of the three species already categorized in Group 1 and Leschenault's Rousette, *Rousettus leschenaultii*, which is not found in Africa."

*For Group 3, the reader is even more at sea, as the referenced article is \"in review\", and all we know is that some machine learning routine sorted out some bat species according to likelihood of filovirus carriage somehow. That two species produced interesting explanatory power is interesting, but they have been drawn from a rather black box.*

Hence we feel that there needs to be a much more thorough consideration of the bat species for the incorporation of these additions to be justified.

We have considerably bolstered this section and added the following text:

"Finally, Group 3 species were identified via generalized boosted regression analysis, which discriminates the bats reported to be filovirus-positive by learning trait patterns that distinguish them from all other bat species (Han et al. 2016). \[...\] This analysis produces a rank list of all bat species according to their probability of being a filovirus carrier on the basis of their trait similarities with known filovirus-positive bat species. Bats found in the 90^th^ percentile of likely filovirus \[...\]"

2\) Coming back to the criteria for inclusion of animal cases, the previous niche map seems to have used only those cases identified by serology and PCR. The current manuscript adds mortality and other clinical symptoms (subsection "Updating the occurrence database", second paragraph), noting this is consistent with inclusion criteria for humans. Importantly, the clinical inclusion criteria for humans are only used in the epidemic zone of a laboratory confirmed outbreak, and this is only for identification of suspect cases who will undergo subsequent laboratory testing (or if this is impossible, epidemiologic criteria may be used to identify probable cases). Ebola is a vague disease in humans, and may be nonspecific in animals. The clinical criteria the authors use are not given, and it is unclear how specific they might be. More information is needed on this to evaluate the suitability of inclusion on clinical grounds.

We have clarified this section. No clinical symptoms were reported in animals beyond fatal outcomes. To avoid confusion, comparisons with the human inclusion criteria and references to clinical symptoms were dropped. We have also added an example of a seropositive animal survey that was excluded due to these criteria. The following sentences are now in the methodology:

"for susceptible species mortality events linked to Ebolavirus by any diagnostic methodology or \[...\]"

"Serological studies were included without fatal outcomes (unlike with susceptible species) due to the hypothesized asymptomatic nature of infection in the reservoir hosts. As a result of these inclusion criteria, studies with serological detection of Ebolavirus in healthy non-Chiropteran species were excluded, such as surveys in dogs (Allela et al. 2005)."

3\) You do not present or discuss how well the newly identified EVD events fit into their previous model. Please consider adding a layer with the previously published model (Figure 5B? from the 2014 publication) on [Figure 1](#fig1){ref-type="fig"} and/ or discuss how the newly identified events fit with the previous model.

We thank the reviewers for suggesting this additional point for discussion. We have added the following within the Results section discussing how these points relate to the previous model:

"Of these new occurrences, two in southern Central African Republic are found in areas predicted to be at-risk by the previous model (Pigott et al. 2014), with the index case from the Democratic Republic of Congo located in close proximity (\<10km) to at-risk areas. The occurrences in Zambia and northern Central African Republic lie, respectively, to the south and north of previously predicted at-risk regions."

*4) Spatial distribution of the human population is not incorporated in the model. It would be useful for more generalist readers to describe briefly how the boosted regression tree modelling takes (or not) into account the fact that it is quite possible that the human population density and environmental variables (including bat population density) are correlated. Hence, a fit with occurrences of zoonotic events might be partly a reflection of population density.*

The boosted regression tree (BRT) model does not incorporate human population density as a covariate. This was done since human population density is unlikely to directly influence the zoonotic transmission of the virus; human index cases likely represent the tip of the iceberg of more widespread viral transmission. That said, human population density will likely influence any detection bias in human cases reported. This potential effect is reflected by using human population to bias the random selection of background or control data points required by the BRT modelling process. Human population density is then used to characterize the populations living in areas at risk, reflecting the fact that whilst some countries have relatively small geographic risk, they are relatively densely populated -- this is highlighted by comparing the populations at risk between Gabon (large geographic area, lower total population) versusNigeria (smaller geographic area, higher total population). We have added two text sections, the first clarifying human population usage in the Materials and methods section and the second looking at the use of absolute population to define risk in the Discussion. We have also fleshed out the modelling section of the methods to clarify which covariates are included and how ecological interaction is dealt with in general:

(in Discussion): "Currently absolute human population residing in at-risk pixels is used as a proxy for spillover likelihood, however a variety of \[...\]"

(in Materials and methods): "A species distribution model, specifically a boosted regression trees approach (Elith et al. 2008), was implemented. \[...\] The boosted regression trees were re-run using the same parameters and covariates (elevation, mean evapotranspiration rate, and mean and range measures of enhanced vegetation index, daytime land surface temperature (LST), and night-time LST) as the previous \[...\]"
